The role of microconstituents on the fatigue failure of bone cement

Abstract

Implant fixation via the use of acrylic bone cement is now a well-established practice in orthopaedics. Excellent long-term clinical results are evidenced in national joint registers based on over 5 decades of clinical experience. Increased life expectancies, patient BMI, together with the need to remain active in later life, are expected to put greater demands on the materials used in load bearing joint arthroplasty. Failure of bone cement and its interfaces with the implant and bone often leads to loosening, requiring revision surgery. This is a particularly invasive procedure, with lower long-term success rates compared to the primary procedure. To reduce the incidence of bone cement failure, it is necessary to understand the origins of failure in vivo. In the past, bulk failure of bone cement has been attributed to damage accumulation originating at pores. Advances in imaging technology now mean that we are able to observe cement microconstituents readily and identify crack-initiating defects more precisely as we attempt to understand origins of failure. The role of radiopacifier particles within the bone cement has not been examined extensively to date, and the present study demonstrates that this microconstituent could be in crack formation due in part to its ability to agglomerate and not bond with the surrounding matrix. To verify this hypothesis, explanted bone cement and laboratory tested bone cement are compared and correlations in failure mechanisms are discussed.